Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04245527
Other study ID # 2216
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 31, 2020
Est. completion date June 1, 2020

Study information

Verified date January 2020
Source ProofPilot
Contact Matthew M Amsden
Phone 3232844626
Email crew@proofpilot.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 1, 2020
Est. primary completion date May 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- United States resident

Exclusion Criteria:

- current Joovv or other photomodulation therapy user

- under medical supervision for medically treatable illness

- significant travel during study period

- use of birth control

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Joovv Infrared Light Device
Joovv is the leading manufacturer of personal, in-home red light therapy devices

Locations

Country Name City State
United States ProofPilot (Virtual Study: https://p.proofpilot.com) New York New York

Sponsors (2)

Lead Sponsor Collaborator
ProofPilot Joovv

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Testosterone Change in males, change from baseline to week 8 baseline to week 8
Primary change of thyroid-stimulating hormone (TSH) in females change in estrogen and progesterone from baseline to week 8 baseline to week 8
Primary Self report general wellness series of questions at baseline and week 8 on general wellness (modified Short Form-36) baseline to week 8
See also
  Status Clinical Trial Phase
Completed NCT03313635 - Evaluation of Prealbumin Levels in Men With Low-T
Completed NCT03528538 - The Efficacy of Fenugreek Supplementation on Men's Health N/A
Completed NCT03091296 - Diurnal Testosterone Concentration
Completed NCT05019859 - Effects of a Low Carb Diet on Erectile Function and Serem Testosterone in Men With Metabolic Syndrome N/A
Completed NCT03282682 - Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male N/A
Terminated NCT03335254 - A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males Phase 1/Phase 2
Completed NCT00512707 - Effect of Testosterone in Men With Erectile Dysfunction Phase 4
Not yet recruiting NCT06343870 - Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) Phase 3
Recruiting NCT06177002 - SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY
Recruiting NCT05096169 - Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate Phase 2
Withdrawn NCT02082197 - An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men Phase 3
Completed NCT00858650 - Registry of Hypogonadism in Men N/A
Not yet recruiting NCT05773183 - Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Withdrawn NCT04717362 - The Effects of Natesto For Treatment Of Hypogonadism Early Phase 1
Not yet recruiting NCT04601233 - Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis Phase 4
Completed NCT04983940 - Patient Satisfaction After Switching to Oral Testosterone Undecanoate Phase 4
Withdrawn NCT04414904 - Determining the Reproductive Health of Men Post-COVID-19 Infection
Completed NCT01963390 - Metabolomics During Testosterone Therapy
Recruiting NCT04460872 - Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury Phase 2
Completed NCT00494208 - TDSM- Testosterone Dose Response in Surgically Menopausal Women N/A